Our laboratory has previously reported the expression and function of B7-H3(+)CD14(+)HLA-DR(–/low) myeloid-derived suppressor cells on human non-small-cell lung cancer (NSCLC) (23). This evidence concerns the gene CD276 and non-small cell lung carcinoma.